AARD

Aardvark Therapeutics (AARD)

About Aardvark Therapeutics (AARD)

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Details

Daily high

$14.64

Daily low

$13.38

Price at open

$13.60

52 Week High

$19.58

52 Week Low

$4.88

Market cap

299.8M

Dividend yield

0.00%

Volume

1.2M

Avg. volume

280,684

P/E ratio

-6.13

Aardvark Therapeutics News